Contact
searchSearch
HMP Global

Atrial Fibrillation News

GLP-1 Medications
New Study Links GLP-1 Medications to Lower Risk of Atrial Fibrillation, Independent of Weight Loss
04/23/2026
Researchers conducted a single-center retrospective study of 13,034 patients who initiated GLP-1-RA therapy between January 2020 and May 2024.
Researchers conducted a single-center retrospective study of 13,034 patients who initiated GLP-1-RA therapy between January 2020 and May 2024.
Researchers conducted a...
04/23/2026
Cath Lab Digest
ACC 2026
Boston Scientific Presents Two Late-Breaking Trials at ACC 2026 Highlighting New Evidence in Stroke Prevention for AFib and Treatment of Intermediate-Risk Pulmonary Embolism
03/30/2026
At the American College of Cardiology (ACC) 2026 Scientific Session, Boston Scientific presented results from two late-breaking randomized controlled trials evaluating device-based approaches in cardiovascular care: CHAMPION-AF, studying the...
At the American College of Cardiology (ACC) 2026 Scientific Session, Boston Scientific presented results from two late-breaking randomized controlled trials evaluating device-based approaches in cardiovascular care: CHAMPION-AF, studying the...
At the American College of...
03/30/2026
Cath Lab Digest
PAD + AF
Significantly Higher Risk for Cardiac Events Including Death are Faced by Patients with Peripheral Arterial Disease Who Also Have Atrial Fibrillation
11/11/2025
“This is a stark reminder that PAD is not just a limb-threatening disease – it’s a marker of widespread atherosclerosis,” said Viet Le, DMSc, MPAS, PA-C, an advanced practice clinician and cardiovascular researcher at Intermountain Health and...
“This is a stark reminder that PAD is not just a limb-threatening disease – it’s a marker of widespread atherosclerosis,” said Viet Le, DMSc, MPAS, PA-C, an advanced practice clinician and cardiovascular researcher at Intermountain Health and...
“This is a stark reminder that...
11/11/2025
Cath Lab Digest
Mitral TEER & AFIB
Patients With Heart Failure and Atrial Fibrillation Undergoing Transcatheter Mitral Edge-to-Edge Repair for Severe Mitral Regurgitation are at Significantly Higher Risk of Death or Rehospitalization
07/23/2025
“AF is a powerful risk marker that we need to take into consideration when planning and performing these procedures,” says corresponding author Stamatios Lerakis, MD, PhD. M-TEER was equally successful in both groups (AF and no AF). However,...
“AF is a powerful risk marker that we need to take into consideration when planning and performing these procedures,” says corresponding author Stamatios Lerakis, MD, PhD. M-TEER was equally successful in both groups (AF and no AF). However,...
“AF is a powerful risk marker...
07/23/2025
EP Lab Digest
News
The Heart Rhythm Society Announces Framework for Establishing Atrial Fibrillation Centers of Excellence and Key Operational Standards
04/23/2025
The Heart Rhythm Society (HRS) releases a framework outlining criteria for establishing an Atrial Fibrillation (AF) Center of Excellence (CoE) and key operational standards to provide multidisciplinary care for AF patients.
The Heart Rhythm Society (HRS) releases a framework outlining criteria for establishing an Atrial Fibrillation (AF) Center of Excellence (CoE) and key operational standards to provide multidisciplinary care for AF patients.
The Heart Rhythm Society (HRS)...
04/23/2025
EP Lab Digest
News
EHRA 2025: Atrial Fibrillation Diagnosed in Midlife is Linked to a 21% Increased Risk of Dementia at Any Age and a 36% Higher Risk of Early-Onset Dementia
03/31/2025
ESC Press Release Vienna, Austria- 31 March 2025 - New research presented at the EHRA 2025, a scientific congress of the European Society of Cardiology, shows that the presence of atrial fibrillation (AF) increases the risk of future...
ESC Press Release Vienna, Austria- 31 March 2025 - New research presented at the EHRA 2025, a scientific congress of the European Society of Cardiology, shows that the presence of atrial fibrillation (AF) increases the risk of future...
ESC Press Release Vienna,...
03/31/2025
EP Lab Digest
News
ACC/AHA: Latest Research Finds People With Certain Heart Conditions May Play Competitive Sports
02/20/2025
Shared decision-making between clinicians and athletes of all ages who have cardiovascular abnormalities and want to participate in competitive sports is essential, according to a new joint scientific statement from the American Heart...
Shared decision-making between clinicians and athletes of all ages who have cardiovascular abnormalities and want to participate in competitive sports is essential, according to a new joint scientific statement from the American Heart...
Shared decision-making between...
02/20/2025
EP Lab Digest
News
Texas Cardiac Arrhythmia Institute at St. David’s Medical Center First in U.S. to Use FDA-Approved Mapping and Dual Energy Ablation Catheter
12/04/2024
Electrophysiologists at the Texas Cardiac Arrhythmia Institute (TCAI) at St. David’s Medical Center recently became the first in the nation to use an all-in-one high-density mapping and dual energy ablation catheter for the treatment of...
Electrophysiologists at the Texas Cardiac Arrhythmia Institute (TCAI) at St. David’s Medical Center recently became the first in the nation to use an all-in-one high-density mapping and dual energy ablation catheter for the treatment of...
Electrophysiologists at the...
12/04/2024
EP Lab Digest
News
A New Hope for Atrial Fibrillation Patients with Breakthrough Catheter Technology
12/04/2024
BTL, a leader in medical innovation, is proud to announce a major milestone: the successful treatment of the first patients suffering from atrial fibrillation (AF) in a groundbreaking study using a next-generation catheter designed to improve...
BTL, a leader in medical innovation, is proud to announce a major milestone: the successful treatment of the first patients suffering from atrial fibrillation (AF) in a groundbreaking study using a next-generation catheter designed to improve...
BTL, a leader in medical...
12/04/2024
EP Lab Digest
News
U.S. FDA Approves AOP Health’s RapiblykTM (landiolol) for Atrial Fibrillation and Atrial Flutter in the Critical Care Setting
12/04/2024
The approval will provide patients in the U.S. with a new treatment option and is an important step for AOP Health in bringing its mission to help patients and make an impact on rare diseases and critical care to the United States for the...
The approval will provide patients in the U.S. with a new treatment option and is an important step for AOP Health in bringing its mission to help patients and make an impact on rare diseases and critical care to the United States for the...
The approval will provide...
12/04/2024
EP Lab Digest

News

Device Longevity
Ten-Year Pivotal Data Demonstrate Long-Term Durability of Edwards Lifesciences’ Resilia Tissue
05/05/2026
The COMMENCE trial provides prospective, 10-year data demonstrating the durability of Edwards’ RESILIA tissue and its role in lifetime management for patients with aortic stenosis.
The COMMENCE trial provides prospective, 10-year data demonstrating the durability of Edwards’ RESILIA tissue and its role in lifetime management for patients with aortic stenosis.
The COMMENCE trial provides...
05/05/2026
Cath Lab Digest
Stroke
Newly Published Study Shows Sensome Clot-Sensing Guidewire Accurately Reveals True Clot Make-Up in Fully Occluded Brain Vessels for First Time
05/05/2026
By integrating the world’s smallest electrical impedance sensor with predictive algorithms into a standard 0.014” guidewire, the Clotild clot-sensing guidewire is designed to provide physicians with real-time, in situ biological intelligence...
By integrating the world’s smallest electrical impedance sensor with predictive algorithms into a standard 0.014” guidewire, the Clotild clot-sensing guidewire is designed to provide physicians with real-time, in situ biological intelligence...
By integrating the world’s...
05/05/2026
Cath Lab Digest
Non-Obstructive HCM
Cytokinetics Announces Positive Topline Results from ACACIA-HCM, the Pivotal Phase 3 Clinical Trial of Aficamten in Patients With Non-Obstructive Hypertrophic Cardiomyopathy
05/05/2026
SOUTH SAN FRANCISCO, Calif. -- Cytokinetics, Incorporated announced positive topline results from ACACIA-HCM (Assessment Comparing Aficamten to Placebo on Cardiac Endpoints In Adults with Non-Obstructive HCM), the pivotal Phase 3...
SOUTH SAN FRANCISCO, Calif. -- Cytokinetics, Incorporated announced positive topline results from ACACIA-HCM (Assessment Comparing Aficamten to Placebo on Cardiac Endpoints In Adults with Non-Obstructive HCM), the pivotal Phase 3...
SOUTH SAN FRANCISCO, Calif. --...
05/05/2026
Cath Lab Digest
Mechanical Circulatory Support
Promising Data from US Pilot Study Shows Planned Impella 5.5 Use is Safe and Feasible in Non-Shock, High-Risk Cardiac Surgery Patients
05/05/2026
Chicago, IL – Johnson & Johnson announced results from a novel U.S. pilot single-arm trial that evaluated the safety and feasibility of planned Impella 5.5™ support in adult patients undergoing cardiac surgery in the setting of...
Chicago, IL – Johnson & Johnson announced results from a novel U.S. pilot single-arm trial that evaluated the safety and feasibility of planned Impella 5.5™ support in adult patients undergoing cardiac surgery in the setting of...
Chicago, IL – Johnson &...
05/05/2026
Cath Lab Digest
Drug-Eluting Balloons
Cordis Launches SELUTION SLR™ PTA Drug-Eluting Balloon (DEB) in Japan 
04/30/2026
The SELUTION SFA Japan clinical trial results demonstrate durable clinical outcomes in a complex patient population, including 81.5% primary patency and 93.8% of patients remaining free from reintervention through three years.(2)
The SELUTION SFA Japan clinical trial results demonstrate durable clinical outcomes in a complex patient population, including 81.5% primary patency and 93.8% of patients remaining free from reintervention through three years.(2)
The SELUTION SFA Japan clinical...
04/30/2026
Cath Lab Digest
J. Dawn Abbott, MD, MSCAI
society news
SCAI Announces J. Dawn Abbott, MD, MSCAI, President for 2026–27
04/30/2026
Dr. Abbott is a nationally recognized leader in interventional cardiology, serving as Professor of Medicine and Director of Interventional Cardiology and the Cardiac Catheterization Laboratories at Brown University Health Cardiovascular...
Dr. Abbott is a nationally recognized leader in interventional cardiology, serving as Professor of Medicine and Director of Interventional Cardiology and the Cardiac Catheterization Laboratories at Brown University Health Cardiovascular...
Dr. Abbott is a nationally...
04/30/2026
Cath Lab Digest
Below-Ankle Intervention
Saving Limbs Where Others Stop: Cagent Vascular Announces Landmark Peer-Reviewed Data Demonstrating Safety and Efficacy of Serration Remodeling Therapy™ in the Most Challenging Arteries Below-the-Ankle
04/29/2026
Serration Remodeling Therapy (SRT) is a novel approach to optimizing luminal gain by gently remodeling the internal elastic lamina through creating a line of weakness to reduce recoil and support durable outcomes.
Serration Remodeling Therapy (SRT) is a novel approach to optimizing luminal gain by gently remodeling the internal elastic lamina through creating a line of weakness to reduce recoil and support durable outcomes.
Serration Remodeling Therapy...
04/29/2026
Vascular Disease Management
Optical Coherence Tomography
Abbott Receives FDA Clearance and CE Mark for Next-Generation Ultreon™ 3.0 AI-Powered Coronary Imaging Platform
04/28/2026
Ultreon 3.0 is the first advanced optical coherence tomography (OCT) system in the U.S. and Europe that integrates high resolution coronary plaque images and AI-automated insights through the artery   The integrated imaging...
Ultreon 3.0 is the first advanced optical coherence tomography (OCT) system in the U.S. and Europe that integrates high resolution coronary plaque images and AI-automated insights through the artery   The integrated imaging...
Ultreon 3.0 is the first...
04/28/2026
Cath Lab Digest
SCAI CAIC logo
SCAI 2026
GLP-1–Based Drug Tirzepatide Reduces Heart Risk in High-Risk Patients
04/27/2026
Studies link treatment to fewer deaths and cardiovascular events after widely used cardiac procedures.
Studies link treatment to fewer deaths and cardiovascular events after widely used cardiac procedures.
Studies link treatment to fewer...
04/27/2026
Journal of Invasive Cardiology
SCAI CAIC logo
SCAI 2026
TAVR Google Searches Surge Over 300% in Past Decade, Corresponding With Expanded Adoption of Transcatheter Approaches
04/27/2026
Search patterns reveal differences in awareness across rural and low-volume treatment areas.
Search patterns reveal differences in awareness across rural and low-volume treatment areas.
Search patterns reveal...
04/27/2026
Journal of Invasive Cardiology

Recent

Original Contribution
Real-World Analysis of Outcomes of Patients Undergoing Coronary Intravascular Lithotripsy Versus Atherectomy for Calcified Coronary Artery Disease: Findings From the TriNetX Database
05/04/2026
Vikash Jaiswal, MD; Muhammad Hanif, MD; Yusra Mashkoor, MBBS; Aymen Ahmed, MBBS; Gregory Mishkel, MD; Jonathan Rosenberg, MD; Mark J. Ricciardi, MD; Arman Qamar, MD, MPH
This real-world study compared outcomes of coronary intravascular lithotripsy vs atherectomy using the TriNetX Global Collaborative Network.
This real-world study compared outcomes of coronary intravascular lithotripsy vs atherectomy using the TriNetX Global Collaborative Network.
This real-world study compared...
05/04/2026
Journal of Invasive Cardiology
Clinical Images
Late Endovascular Aneurysm Repair Limb Occlusion Presenting as Claudication: Lifelong Surveillance Essential
05/04/2026
Ping Hu, MD; Xin-yu Wang, MD; Ming Qi, MD; Jie Wang, MD; Xiao-Jing Ma, PhD
A 55-year-old man presented with medically controlled essential hypertension and a history of abdominal aortic aneurysm stenting 2 years prior who presented with a 3-month history of left lower extremity fatigue on exertion.
A 55-year-old man presented with medically controlled essential hypertension and a history of abdominal aortic aneurysm stenting 2 years prior who presented with a 3-month history of left lower extremity fatigue on exertion.
A 55-year-old man presented with...
05/04/2026
Journal of Invasive Cardiology
Brief Communication
Clinical Outcomes After Transcatheter Aortic Valve Replacement by Sex and Subtype of Low-Flow Aortic Stenosis
05/04/2026
Eileen Galvani, MD; Oludamilola Akinmolayemi, MD, MPH; Srivatsan Swaminathan, BS; Carlo Mannina, MD; Sahil Khera, MD, MPH; Lucy M. Safi, DO; Gilbert H.L. Tang, MD, MSc, MBA; Samin K. Sharma, MD; Annapoorna S. Kini, MD; Stamatios Lerakis, MD, PhD
The authors hypothesized that among patients with low-flow aortic stenosis (LFAS), outcomes differ based on sex and subtype of LFAS: classical, paradoxical, and high gradient.
The authors hypothesized that among patients with low-flow aortic stenosis (LFAS), outcomes differ based on sex and subtype of LFAS: classical, paradoxical, and high gradient.
The authors hypothesized that...
05/04/2026
Journal of Invasive Cardiology
SCAI CAIC logo
SCAI 2026
Pivotal Structural and Coronary Trials Driving Practice Change in 2025
04/30/2026
Laura Simson, MA
This 2026 SCAI session highlighted the most influential trial data across coronary and structural heart disease from 2025.
This 2026 SCAI session highlighted the most influential trial data across coronary and structural heart disease from 2025.
This 2026 SCAI session...
04/30/2026
Journal of Invasive Cardiology
Clinical Images
Caught in the Web: Alteplase-Assisted Rescue of an Entrapped Pericardial Pigtail
04/30/2026
Swaminathan Krishnaswamy, MBBS, MD; Shivam Goel, MBBS, MD, DM; Shashwat Joshi, MBBS; Ankur Handa, MBBS, MD, DM; Sivasubramanian Ramakrishnan, MBBS, MD, DM; Sourabh Agstam, MBBS, MD, DM
A 12-year-old boy with a case of disseminated tuberculosis who was on guideline-directed oral antitubercular therapy presented to the outpatient clinic with worsening exertional dyspnea for the past 2 months.
A 12-year-old boy with a case of disseminated tuberculosis who was on guideline-directed oral antitubercular therapy presented to the outpatient clinic with worsening exertional dyspnea for the past 2 months.
A 12-year-old boy with a case of...
04/30/2026
Journal of Invasive Cardiology
Original Contribution
Extracorporeal Versus Conventional Cardiopulmonary Resuscitation for Out-of-Hospital Cardiac Arrests
04/29/2026
Tara Seirafi; Jeremy Y. Levett, MD; Areesha Moiz, MSc; Tetiana Zolotarova, MD; Kristian B. Filion, PhD; Adelina Dobromir Angheluta; Pauline Reynier, MSc; Mark J. Eisenberg, MD, MPH
The authors sought to determine the efficacy of extracorporeal cardiopulmonary resuscitation vs conventional cardiopulmonary resuscitation among patients with out-of-hospital cardiac arrests in the pre-hospital setting.
The authors sought to determine the efficacy of extracorporeal cardiopulmonary resuscitation vs conventional cardiopulmonary resuscitation among patients with out-of-hospital cardiac arrests in the pre-hospital setting.
The authors sought to determine...
04/29/2026
Journal of Invasive Cardiology
SCAI CAIC logo
SCAI 2026
Association of Tirzepatide Use With Clinical Outcomes After Transcatheter Aortic Valve Replacement in Obese Patients: A Propensity-Matched Real-World Study
04/27/2026
Ibrahim Mortada, MD
Dr Ibrahim Mortada shares insights on his study, "Association of Tirzepatide Use with Clinical Outcomes After TAVR in Obese Patients: A Propensity-Matched Real-World Study," presented at the 2026 SCAI Scientific Sessions.
Dr Ibrahim Mortada shares insights on his study, "Association of Tirzepatide Use with Clinical Outcomes After TAVR in Obese Patients: A Propensity-Matched Real-World Study," presented at the 2026 SCAI Scientific Sessions.
Dr Ibrahim Mortada shares...
04/27/2026
Journal of Invasive Cardiology
Original Contribution
The Prevalence of Cardiac Symptoms in Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorder: A Pilot Study
04/21/2026
Ermin Tale, DO; Riya Kaushal, BA; Bilal Niazi, BS; Katie Nikishina, BA; Amy Chen, MS; Bernadette Riley, DO; Todd J. Cohen, MD
The authors compared palpitations, presyncope, syncope, and postural orthostatic tachycardia syndrome prevalence among patients with hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorder.
The authors compared palpitations, presyncope, syncope, and postural orthostatic tachycardia syndrome prevalence among patients with hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorder.
The authors compared...
04/21/2026
Journal of Invasive Cardiology
Clinical Images
Controlled Antegrade and Retrograde Tracking (CART) Technique Via Epicardial Collaterals: Feasible and Safe
04/21/2026
Tarek Abdeldayem, MD; Mustafa Tigen, MD; Omer Gogtekin, MD; Mohaned Egred, BSc (Hons), MB, ChB, MD, FRCP, FESC
A 59-year-old man with exertional angina and coronary angiography showing chronic total occlusion of the right coronary artery with collateral filling from the left anterior descending artery. Dual injection revealed an ambiguous proximal...
A 59-year-old man with exertional angina and coronary angiography showing chronic total occlusion of the right coronary artery with collateral filling from the left anterior descending artery. Dual injection revealed an ambiguous proximal...
A 59-year-old man with...
04/21/2026
Journal of Invasive Cardiology
Clinical Images
Optical Coherence Tomography Features in Coronary Vasculitis: A Takayasu’s Disease Manifestation
04/17/2026
Nicolás del Cuerpo Salinas, MD; Eduardo Arroyo Úcar, MD, PhD; Ignacio Alfaro Paniagua, MD; Marta Monteagudo Viana, MD, PhD; María Araceli Frutos García, MD
A 53-year-old man with a history of Takayasu arteritis, Crohn’s disease, and HLA-B27-negative spondyloarthritis presented with unstable angina, prompting coronary angiography. Angiography revealed a long, angiographically intermediate lesion...
A 53-year-old man with a history of Takayasu arteritis, Crohn’s disease, and HLA-B27-negative spondyloarthritis presented with unstable angina, prompting coronary angiography. Angiography revealed a long, angiographically intermediate lesion...
A 53-year-old man with a history...
04/17/2026
Journal of Invasive Cardiology

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use